Healthcare provider profile · identity verified

Susan Ramirez, MD

Internal Medicine · SCHERERVILLE, IN · NPI 1861459364

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	404	127
Losartan Potassium	Losartan Potassium	368	101
Amlodipine Besylate	Amlodipine Besylate	326	103
Levothyroxine Sodium	Levothyroxine Sodium	315	97
Lisinopril	Lisinopril	276	86
Rosuvastatin Calcium	Rosuvastatin Calcium	252	86
Hydrochlorothiazide	Hydrochlorothiazide	214	67
Metoprolol Succinate	Metoprolol Succinate	205	68
Omeprazole	Omeprazole	181	59
Metformin Hcl	Metformin Hcl	179	52
Pantoprazole Sodium	Pantoprazole Sodium	169	52
Montelukast Sodium	Montelukast Sodium	155	50
Famotidine	Famotidine	147	51
Simvastatin	Simvastatin	129	36
Sertraline Hcl	Sertraline Hcl	122	33
Meloxicam	Meloxicam	118	37
Furosemide	Furosemide	100	29
Hydralazine Hcl	Hydralazine Hcl	100	30
Potassium Chloride	Potassium Chloride	99	30
Carvedilol	Carvedilol	96	30
Pravastatin Sodium	Pravastatin Sodium	84	23
Metoprolol Tartrate	Metoprolol Tartrate	82	28
Atenolol	Atenolol	80	19
Escitalopram Oxalate	Escitalopram Oxalate	77	17
Gabapentin	Gabapentin	76	29
Ozempic	Semaglutide	75	15
Duloxetine Hcl	Duloxetine Hcl	73	17
Allopurinol	Allopurinol	71	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	29
Tamsulosin Hcl	Tamsulosin Hcl	66	26
Trazodone Hcl	Trazodone Hcl	64	21
Albuterol Sulfate Hfa	Albuterol Sulfate	58	20
Glimepiride	Glimepiride	56	19
Olmesartan Medoxomil	Olmesartan Medoxomil	55	15
Farxiga	Dapagliflozin Propanediol	53	14
Ezetimibe	Ezetimibe	52	17
Meclizine Hcl	Meclizine Hcl	52	18
Clopidogrel	Clopidogrel Bisulfate	48	17
Irbesartan	Irbesartan	47	14
Synthroid	Levothyroxine Sodium	46	16
Prednisone	Prednisone	43	36
Metformin Hcl Er	Metformin Hcl	42	13
Azithromycin	Azithromycin	40	39
Donepezil Hcl	Donepezil Hcl	40	15
Sucralfate	Sucralfate	40	14
Trulicity	Dulaglutide	38	suppressed
Glipizide Er	Glipizide	35	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	33	11
Valsartan	Valsartan	33	suppressed
Glipizide	Glipizide	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Telmisartan	Telmisartan	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	11
Citalopram Hbr	Citalopram Hydrobromide	29	15
Fluticasone Propionate	Fluticasone Propionate	29	13
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	18
Lactulose	Lactulose	25	15
Ramipril	Ramipril	25	suppressed
Eliquis	Apixaban	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nystatin	Nystatin	24	13
Dicyclomine Hcl	Dicyclomine Hcl	23	11
Januvia	Sitagliptin Phosphate	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Metronidazole	Metronidazole	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Hydrocortisone	Hydrocortisone	20	11
Ibuprofen	Ibuprofen	20	suppressed
Levofloxacin	Levofloxacin	20	19
Naproxen	Naproxen	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Np Thyroid	Thyroid,pork	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Colchicine	Colchicine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Mupirocin	Mupirocin	16	11
Tradjenta	Linagliptin	16	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	15	suppressed
Jardiance	Empagliflozin	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Rivastigmine	Rivastigmine	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Phenytoin	Phenytoin	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error